Vermont · 2025-2026 Regular Session · Bill
H 202: An act relating to increasing the transparency of prescription drug costs and spending
Introduced Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 202 is a bill introduced in the Vermont House on February 12, 2025. According to its official title, it concerns: An act relating to increasing the transparency of prescription drug costs and spending. Primary sponsor: Mari Cordes. Most recent recorded action (February 12, 2025): Read first time and referred to the Committee on Health Care.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Mari Cordes | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Read first time and referred to the Committee on Health Care